Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Nitish Kumar, Bharat Khurana & Daisy Arora. (2023) Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions. Pharmaceutical Development and Technology 0:0, pages 1-16.
Read now
Read now
Gamze Camlik, Besa Bilakaya, Yildiz Ozsoy & Ismail Tuncer Degim. (2023) A new approach for the treatment of Alzheimer’s disease: insulin-quantum dots. Journal of Microencapsulation 0:0, pages 1-9.
Read now
Read now
Bassant Elbardisy, Sally Galal, Doaa A. Abdelmonsif & Nabila Boraie. (2019) Intranasal Tadalafil nanoemulsions: formulation, characterization and pharmacodynamic evaluation. Pharmaceutical Development and Technology 24:9, pages 1083-1094.
Read now
Read now
Hanieh Gholizadeh, Shaokoon Cheng, Michele Pozzoli, Elisa Messerotti, Daniela Traini, Paul Young, Agisilaos Kourmatzis & Hui Xin Ong. (2019) Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders. Expert Opinion on Drug Delivery 16:4, pages 453-466.
Read now
Read now
Maryam Khatoon, Kifayat Ullah Shah, Fakhar Ud Din, Shefaat Ullah Shah, Asim Ur Rehman, Naz Dilawar & Ahmad Nawaz Khan. (2017) Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug Delivery 24:2, pages 56-69.
Read now
Read now
Taiyoun Rhim & Minhyung Lee. (2016) Targeted delivery of growth factors in ischemic stroke animal models. Expert Opinion on Drug Delivery 13:5, pages 709-723.
Read now
Read now
Amrish Kumar, Aditya Nath Pandey & Sunil Kumar Jain. (2016) Nasal-nanotechnology: revolution for efficient therapeutics delivery. Drug Delivery 23:3, pages 671-683.
Read now
Read now
Sonali S Bharate & Ram A Vishwakarma. (2013) Impact of preformulation on drug development. Expert Opinion on Drug Delivery 10:9, pages 1239-1257.
Read now
Read now
Reena MP Singh, Anil Kumar & Kamla Pathak. (2013) Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery. Expert Opinion on Drug Delivery 10:1, pages 115-130.
Read now
Read now
Articles from other publishers (79)
Someshbabu Ramesh Babu, Harshith Hosahalli Shekara, Ashish Kumar Sahoo, Pyda Venkata Harsha Vardhan, Nitheesh Thiruppathi & Madhugiri Prakash Venkatesh. (2023) Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review. Therapeutic Delivery 14:9, pages 571-594.
Crossref
Crossref
Rohit R Doke, Tejas S Naik, Disha L Lamkhade, Tanaya S Bhise, Vikrant N Khokrale & Yuvraj B Gosavi. (2023) Novel therapeutic delivery for neurodegenerative diseases: Strategies to overcome CNS barriers. Journal of Pharmaceutical and Biological Sciences 11:1, pages 1-8.
Crossref
Crossref
Enas Elmowafy & Mahmoud E. Soliman. (2023) Polysaccharide-based platforms for nasal delivery: design, features, and perspectives. Journal of Pharmaceutical Investigation.
Crossref
Crossref
Rajat Garg & Anuj Garg. (2023) A Comprehensive Review on Recent Advances and Considerations for the
Selection of Cell-based In-vitro Techniques for the Assessment of
Permeability of Drug Molecules. Current Drug Delivery 20:5, pages 526-544.
Crossref
Crossref
Sachin Nashik Sanap, Amol Chhatrapati Bisen, Ashwini Kedar, Sristi Agrawal & Rabi Sankar Bhatta. (2023) Recent Update on Pharmacokinetics and Drug Metabolism in CNS-based Drug
Discovery. Current Pharmaceutical Design 29:20, pages 1602-1616.
Crossref
Crossref
Varunesh Sanjay Tambe & Sarika Wairkar. (2023) Lipid-based Nanocarriers via Nose-to-Brain Pathway for Alzheimer's and
Parkinson's Disease. Current Nanoscience 19:3, pages 322-337.
Crossref
Crossref
Anja Haasbroek‐Pheiffer, Suzanne Van Niekerk, Frank Van der Kooy, Theunis Cloete, Jan Steenekamp & Josias Hamman. (2023)
In vitro
and
ex vivo
experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery
. Biopharmaceutics & Drug Disposition 44:1, pages 94-112.
Crossref
Crossref
Shiv Bahadur & Anubhav Prakash. (2023) A Comprehensive Review on Nanomedicine: Promising Approach for
Treatment of Brain Tumor through Intranasal Administration. Current Drug Targets 24:1, pages 71-88.
Crossref
Crossref
Deepshi Arora, Shailendra Bhatt, Manish Kumar, Rupesh K. Gautam, Yugam Taneja & Muskan Chauhan. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research
447
477
.
Jéssica Bassi da Silva, Maria Vitoria Gouveia Botan & Marcos Luciano Bruschi. 2023. Nasal Drug Delivery. Nasal Drug Delivery
43
58
.
Muhammad Sarfraz, Sara Mousa, Ranim Al Saoud & Raimar Löbenberg. 2023. Nasal Drug Delivery. Nasal Drug Delivery
339
360
.
Bhakti Pawar, Nupur Vasdev, Tanisha Gupta, Mahi Mhatre, Anand More, Neelima Anup & Rakesh Kumar Tekade. (2022) Current Update on Transcellular Brain Drug Delivery. Pharmaceutics 14:12, pages 2719.
Crossref
Crossref
Shiv Bahadur & Manas Kumar Jha. (2022) Emerging nanoformulations for drug targeting to brain through intranasal delivery: A comprehensive review. Journal of Drug Delivery Science and Technology 78, pages 103932.
Crossref
Crossref
Cecilia de Barros, Isabella Portugal, Fernando Batain, Décio Portella, Patrícia Severino, Juliana Cardoso, Plinio Arcuri, Marco Chaud & Thais Alves. (2022) Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems. RPS Pharmacy and Pharmacology Reports 1:1.
Crossref
Crossref
Darshana Patel & Hetal Thakkar. (2022) Formulation considerations for improving intranasal delivery of CNS acting therapeutics. Therapeutic Delivery 13:7, pages 371-381.
Crossref
Crossref
Oveis Pourmehran, Benjamin Cazzolato, Zhao Tian & Maziar Arjomandi. (2022) The effect of inlet flow profile and nozzle diameter on drug delivery to the maxillary sinus. Biomechanics and Modeling in Mechanobiology 21:3, pages 849-870.
Crossref
Crossref
T.L. Olatunji, F. Siebert, A.E. Adetunji, B.H. Harvey, J. Gericke, J.H. Hamman & F. Van der Kooy. (2022) Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological, pre-clinical and clinical activities. Journal of Ethnopharmacology 287, pages 114711.
Crossref
Crossref
Yogesh Garg, Deepak N. Kapoor, Abhishek K. Sharma & Amit Bhatia. (2022) Drug Delivery Systems and Strategies to Overcome the Barriers of Brain. Current Pharmaceutical Design 28:8, pages 619-641.
Crossref
Crossref
Hamidreza Mortazavy Beni, Hamed Mortazavi & Mohammad Saidul Islam. (2021) Biomedical and biophysical limits to mathematical modeling of pulmonary system mechanics: a scoping review on aerosol and drug delivery. Biomechanics and Modeling in Mechanobiology 21:1, pages 79-87.
Crossref
Crossref
Harsha Jain, Harshita Dalvi, Aditi Bhat, Aashruti Agrawal, Jitender Madan, Pankaj Kumar Singh, Neelesh Kumar Mehra, Shashi Bala Singh & Saurabh Srivastava. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
379
400
.
Naomi Ketharanathan, Ursula K. Rohlwink, Anthony A. Figaji, Enno D. Wildschut, Dick Tibboel & Elizabeth C.M. de Lange. 2022. Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury. Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury
231
242
.
Fakhara Sabir, Qurrat Ul Ain, Abbas Rahdar, Zhugen Yang, Mahmood Barani, Mauhammad Bilal & Nikhil Bhalla. 2022. Synthesis and Applications of Nanoparticles. Synthesis and Applications of Nanoparticles
455
485
.
N. N. Porfiryeva, I. I. Semina, R. I. Moustafine & V. V. Khutoryanskiy. (2021) Intranasal Administration as a Route to Deliver Drugs to the Brain (Review). Drug development & registration 10:4, pages 117-127.
Crossref
Crossref
T.L. Olatunji, F. Siebert, A.E. Adetunji, B.H. Harvey, J. Gericke, J.H. Hamman & F. Van der Kooy. (2021) Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological and clinical activities. Journal of Ethnopharmacology 280, pages 114476.
Crossref
Crossref
Hetal P. Patel, Priyanshi A. Gandhi, Priyanka S. Chaudhari, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Furqan A. Maulvi & Bhavin A. Vyas. (2021) Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology 64, pages 102533.
Crossref
Crossref
Laura Deruyver, Clément Rigaut, Pierre Lambert, Benoît Haut & Jonathan Goole. (2021) The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Advanced Drug Delivery Reviews 175, pages 113826.
Crossref
Crossref
Hussein Akel, Ruba Ismail, Gábor Katona, Fakhara Sabir, Rita Ambrus & Ildikó Csóka. (2021) A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. International Journal of Pharmaceutics 604, pages 120724.
Crossref
Crossref
Hetal P. Patel, Priyanka S. Chaudhari, Priyanshi A. Gandhi, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Bhavin A. Vyas & Furqan A. Maulvi. (2021) Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. International Journal of Pharmaceutics 600, pages 120474.
Crossref
Crossref
John Chen, Andrew R. Martin & Warren H. Finlay. (2021) Recent In Vitro and In Silico Advances in the Understanding of Intranasal Drug Delivery. Current Pharmaceutical Design 27:12, pages 1482-1497.
Crossref
Crossref
Anna Andrzejewska, Sylwia Dabrowska, Barbara Lukomska & Miroslaw Janowski. (2021) Mesenchymal Stem Cells for Neurological Disorders. Advanced Science 8:7.
Crossref
Crossref
Ketao Jin, Chunsen Mao, Lin Chen, Lude Wang, Yuyao Liu & Jianlie Yuan. (2021) Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma. Cancers 13:2, pages 229.
Crossref
Crossref
Abhijeet Pandey, Ajinkya Nikam, Shreya Basavraj, Sadhana Mutalik, Divya Gopalan, Sanjay Kulkarni, Bharat Padya, Gasper Fernandes & Srinivas Mutalik. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
495
522
.
Amarjitsing Rajput, Nikunj Tandel, Swapnil Borse & Shital Butani. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
389
404
.
Shiv Bahadur & Kamla Pathak. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
187
207
.
Umesh D. Laddha & Amol A. Tagalpallewar. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
39
54
.
Bruno Fonseca-Santos & Marlus Chorilli. (2020) The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems. International Journal of Pharmaceutics 589, pages 119832.
Crossref
Crossref
Rucheera R. Verekar, Shailendra S. Gurav & Udaykumar Bolmal. (2020) Thermosensitive mucoadhesive in situ gel for intranasal delivery of Almotriptan malate: Formulation, characterization, and evaluation. Journal of Drug Delivery Science and Technology 58, pages 101778.
Crossref
Crossref
Anastasia Detsi, Eleni Kavetsou, Ioanna Kostopoulou, Ioanna Pitterou, Antonella Rozaria Nefeli Pontillo, Andromachi Tzani, Paris Christodoulou, Aristeia Siliachli & Panagiotis Zoumpoulakis. (2020) Nanosystems for the Encapsulation of Natural Products: The Case of Chitosan Biopolymer as a Matrix. Pharmaceutics 12:7, pages 669.
Crossref
Crossref
Ravindra V. Badhe & Sonali S. Nipate. 2020. Bioadhesives in Drug Delivery. Bioadhesives in Drug Delivery
259
305
.
Shiv Bahadur, Nidhi Sachan, Ranjit K. Harwansh & Rohitas Deshmukh. (2020) Nanoparticlized System: Promising Approach for the Management of Alzheimer’s Disease through Intranasal Delivery. Current Pharmaceutical Design 26:12, pages 1331-1344.
Crossref
Crossref
Hussein Akel, Ruba Ismail & Ildikó Csóka. (2020) Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease. European Journal of Pharmaceutics and Biopharmaceutics 148, pages 38-53.
Crossref
Crossref
J. H. Azambuja, R. S. Schuh, L. R. Michels, N. E. Gelsleichter, L. R. Beckenkamp, I. C. Iser, G. S. Lenz, F. H. de Oliveira, G. Venturin, S. Greggio, J. C. daCosta, M. R. Wink, J. Sevigny, M. A. Stefani, A. M. O. Battastini, H. F. Teixeira & E. Braganhol. (2019) Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach. Molecular Neurobiology 57:2, pages 635-649.
Crossref
Crossref
Sara Salatin, Jaleh BararMohammad Barzegar-JalaliKhosro AdibkiaMitra Alami-MilaniMitra Jelvehgari. (2019) Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine. Advanced Pharmaceutical Bulletin 10:1, pages 20-29.
Crossref
Crossref
Luana R. Michels, Flávia N.S. Fachel, Juliana H. Azambuja, Nicolly E. Gelsleichter, Elizandra Braganhol & Helder F. Teixeira. (2019)
HPLC–UV method for temozolomide determination in complex biological matrices: Application for
in vitro
,
ex vivo
and
in vivo
studies
. Biomedical Chromatography 33:10.
Crossref
Crossref
Simone Ladel, Patrick Schlossbauer, Johannes Flamm, Harald Luksch, Boris Mizaikoff & Katharina Schindowski. (2019) Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650. Pharmaceutics 11:8, pages 367.
Crossref
Crossref
Franciele Bruinsmann, Stefania Pigana, Tanira Aguirre, Gabriele Souto, Gabriela Pereira, Annalisa Bianchera, Laura Fasiolo, Gaia Colombo, Magno Marques, Adriana Pohlmann, Silvia Guterres & Fabio Sonvico. (2019) Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery. Pharmaceutics 11:2, pages 86.
Crossref
Crossref
Chunhua Chen, Mengqin Zhang, Yejun Wu, Changman Zhou & Renyu Liu. 2019. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders
75
89
.
D. B. Trushina, T. N. Borodina, S. N. Sulyanov, J. V. Moiseeva, N. V. Gulyaeva & T. V. Bukreeva. (2018) Comparison of the Structural Features of Micron and Submicron Vaterite Particles and Their Efficiency for Intranasal Delivery of Anesthetic to the Brain. Crystallography Reports 63:6, pages 998-1004.
Crossref
Crossref
Stella Gänger & Katharina Schindowski. (2018) Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa. Pharmaceutics 10:3, pages 116.
Crossref
Crossref
P. Szabó-Révész. (2018) Modifying the physicochemical properties of NSAIDs for nasal and pulmonary administration. Drug Discovery Today: Technologies 27, pages 87-93.
Crossref
Crossref
Milad Kiaee, Herbert Wachtel, Michelle L. Noga, Andrew R. Martin & Warren H. Finlay. (2018) Regional deposition of nasal sprays in adults: A wide ranging computational study. International Journal for Numerical Methods in Biomedical Engineering 34:5, pages e2968.
Crossref
Crossref
Csilla Bartos, Rita Ambrus, Anita Kovács, Róbert Gáspár, Anita Sztojkov-Ivanov, Árpád Márki, Tamás Janáky, Ferenc Tömösi, Gábor Kecskeméti & Piroska Szabó-Révész. (2018) Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems. Molecules 23:4, pages 784.
Crossref
Crossref
Kamla Pathak, Satyanarayan Pattnaik & Kalpana Swain. 2018. Nanoemulsions. Nanoemulsions
415
433
.
Jingliang Dong, Yidan Shang, Kiao Inthavong, Hak-Kim Chan & Jiyuan Tu. (2017) Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery. Pharmaceutical Research 35:1.
Crossref
Crossref
Javier Morán, Anna Stokowska, Frederik R. Walker, Carina Mallard, Henrik Hagberg & Marcela Pekna. (2017) Intranasal C3a treatment ameliorates cognitive impairment in a mouse model of neonatal hypoxic–ischemic brain injury. Experimental Neurology 290, pages 74-84.
Crossref
Crossref
Ejaj Ahmad, Yunhai Feng, Jianping Qi, Wufa Fan, Yuhua Ma, Haisheng He, Fei Xia, Xiaochun Dong, Weili Zhao, Yi Lu & Wei Wu. (2017) Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles. Nanoscale 9:3, pages 1174-1183.
Crossref
Crossref
Elissar Andari, Rene Hurlemann & Larry J. Young. 2018. Behavioral Pharmacology of Neuropeptides: Oxytocin. Behavioral Pharmacology of Neuropeptides: Oxytocin
559
590
.
Anam Khan, Syed Sarim Imam, Mohammed Aqil, Abdul Ahad, Yasmin Sultana, Asgar Ali & Khalid Khan. (2016) Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses. Molecular Pharmaceutics 13:11, pages 3773-3782.
Crossref
Crossref
Remigius U Agu. (2016) Challenges in nasal drug absorption: how far have we come?. Therapeutic Delivery 7:7, pages 495-510.
Crossref
Crossref
Daniel Antunes Viegas, Márcio Rodrigues, Joana Francisco, Amílcar Falcão, Gilberto Alves & Adriana O. Santos. (2016) Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method. European Journal of Pharmaceutical Sciences 89, pages 61-72.
Crossref
Crossref
Ye Tian, Yujiao Sun, Xiaodan Wang, Georgios Kasparis & Shirui Mao. 2016. Nanobiomaterials in Drug Delivery. Nanobiomaterials in Drug Delivery
515
572
.
Santosh Shelke, Sadhana Shahi, Sunil Jalalpure, Dinesh Dhamecha & Sushant Shengule. (2015) Formulation and evaluation of thermoreversible mucoadhesive in-situ gel for intranasal delivery of naratriptan hydrochloride. Journal of Drug Delivery Science and Technology 29, pages 238-244.
Crossref
Crossref
Yogesh K. Katare, Ritesh P. Daya, Christal Sookram Gray, Roger E. Luckham, Jayant Bhandari, Abhay S. Chauhan & Ram K. Mishra. (2015) Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer. Molecular Pharmaceutics 12:9, pages 3380-3388.
Crossref
Crossref
Burel R. Goodin, Austen J. B. Anderson, Emily L. Freeman, Hailey W. Bulls, Meredith T. Robbins & Timothy J. Ness. (2015) Intranasal Oxytocin Administration is Associated With Enhanced Endogenous Pain Inhibition and Reduced Negative Mood States. The Clinical Journal of Pain 31:9, pages 757-767.
Crossref
Crossref
Steven Lehrer & Peter H. Rheinstein. (2014) Is Alzheimer’s Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs?. American Journal of Alzheimer's Disease & Other Dementiasr 30:3, pages 225-227.
Crossref
Crossref
Yan-hua Li, Ling Feng, Guang-Xian Zhang & Cun-gen Ma. (2015) Intranasal delivery of stem cells as therapy for central nervous system disease. Experimental and Molecular Pathology 98:2, pages 145-151.
Crossref
Crossref
Daniel S. Quintana, Gail A. Alvares, Ian B. Hickie & Adam J. Guastella. (2015) Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model. Neuroscience & Biobehavioral Reviews 49, pages 182-192.
Crossref
Crossref
Jayrajsinh Sarvaiya & Y.K. Agrawal. (2015) Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery. International Journal of Biological Macromolecules 72, pages 454-465.
Crossref
Crossref
Yan-Hua Li, Jie-Zhong Yu, Chun-Yun Liu, Hui Zhang, Hai-Fei Zhang, Wan-Fang Yang, Jun-Lian Li, Qian-Jin Feng, Ling Feng, Guang-Xian Zhang, Bao-Guo Xiao & Cun-Gen Ma. (2014) Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis. Immunology 143:2, pages 219-229.
Crossref
Crossref
Ana Fortuna, Gilberto Alves, Ana Serralheiro, Joana Sousa & Amílcar Falcão. (2014) Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 8-27.
Crossref
Crossref
Steven Lehrer. (2014) Nasal NSAIDs for Alzheimer's Disease. American Journal of Alzheimer's Disease & Other Dementiasr 29:5, pages 401-403.
Crossref
Crossref
Giovanni Tosi, Antonietta Vilella, Resham Chhabra, Michael J. Schmeisser, Tobias M. Boeckers, Barbara Ruozi, Maria Angela Vandelli, Flavio Forni, Michele Zoli & Andreas M. Grabrucker. (2014) Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport. Journal of Controlled Release 177, pages 96-107.
Crossref
Crossref
Teresa Musumeci, Rosalia Pellitteri, Michela Spatuzza & Giovanni Puglisi. (2014) Nose-to-Brain Delivery: Evaluation of Polymeric Nanoparticles on Olfactory Ensheathing Cells Uptake. Journal of Pharmaceutical Sciences 103:2, pages 628-635.
Crossref
Crossref
Youl-Ri KimSeung-Min OhFreya CorfieldDa-Woon JeongEun-Young JangJanet Treasure. (2014) Intranasal Oxytocin Lessens the Attentional Bias to Adult Negative Faces: A Double Blind within-Subject Experiment. Psychiatry Investigation 11:2, pages 160.
Crossref
Crossref
Taiyoun Rhim, Dong Yun Lee & Minhyung Lee. (2013) Drug Delivery Systems for the Treatment of Ischemic Stroke. Pharmaceutical Research 30:10, pages 2429-2444.
Crossref
Crossref
Adam J. Guastella, Ian B. Hickie, Margaret M. McGuinness, Melissa Otis, Elizabeth A. Woods, Hannah M. Disinger, Hak-Kim Chan, Timothy F. Chen & Richard B. Banati. (2013) Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology 38:5, pages 612-625.
Crossref
Crossref
Julie D. Suman. (2013) Current understanding of nasal morphology and physiology as a drug delivery target. Drug Delivery and Translational Research 3:1, pages 4-15.
Crossref
Crossref
Ana Serralheiro, Gilberto Alves, Joana Sousa, Ana Fortuna & Amílcar Falcão. 2013. Nasal Physiology and Pathophysiology of Nasal Disorders. Nasal Physiology and Pathophysiology of Nasal Disorders
191
215
.
Andreas M. Grabrucker, Resham Chhabra, Daniela Belletti, Flavio Forni, Maria Angela Vandelli, Barbara Ruozi & Giovanni Tosi. 2014. The Blood Brain Barrier (BBB). The Blood Brain Barrier (BBB)
71
89
.